Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AngioDynamics Inc ANGO

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.


NDAQ:ANGO - Post by User

Bullboard Posts
Next >>
Post by investorblingon Jan 03, 2007 10:38am
233 Views
Post# 11947954

Recommendations for January 3, 2007

Recommendations for January 3, 2007

The Bomb

 Company  Recommendation Current Price  Target Price  Analyst  Analyst Rating 
Weyerhaeuser Co. Market Perform $70.65 $75.00 S.A. 3 Stars
Algonquin Power Income Fund Underperform  $9.66 $8.25 K.T & M.M. 3 Stars (both)
Domtar  Outperform  $9.75 $12.00 S.A. 3 Stars
Encana  Outperform  $45.95(us)  $62.00(us) R.O.  --------

Concorde

Company  Recommendation  Current price  Target price  Analyst  Analyst Rating 
AngioDynamics  Buy  $21.49  $26.00  M.S.  -------- 
AtheroGenics  Buy  $9.91  $19.00  J.P.  -------- 
Badger Meter  Buy  $27.70  $30.00  J.Q.  3 Stars 
Cell Genesys  Buy  $3.39  $7.00  J.P.  -------- 
Nanometrics  Buy  $7.91  $12  A.K.  3 Stars 
Pharmcopeia Drug Discovery  Buy  $4.26  $7  J.P.  -------- 
Quantum Technologies  Buy  $1.60  $3  J.Q.  3 Stars 
Tusk Energy Corp.  Speculative Buy  $3.07  $5  R.W.  -------- 
Venenex Energy Inc.  Speculative Buy  $6.76  $9.65  R.W.  -------- 

See I See You

No Recommendations Today.

Bullboard Posts
Next >>